Oncolytics Biotech Inc. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Oncolytics Biotech Inc., a foreign private issuer based in Calgary, Alberta, Canada, on March 16, 2007. The report pertains to the month of March 2007 and serves to furnish an amended Auditor's Report related to the Company's audited financial statements for the period ended December 31, 2006.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is an administrative correction to a previously filed audit report and does not contain new financial data or performance metrics.
Material Changes
The only material change disclosed is a correction to the date on the Auditor's Report. The original report, dated February 23, 2006, contained a typographical error. The amended report corrects this date to February 23, 2007. The filing explicitly states that no other changes have been made to the Auditor's Report.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, outlook, or discussion of risks and contingencies. The document is strictly limited to the correction of the audit report date.
Key Facts for Investor Verification
- The filing corrects a typographical error in the date of the Auditor's Report for the fiscal year ended December 31, 2006.
- The corrected date on the Auditor's Report is February 23, 2007.
- The original Annual Report on Form 40-F was dated March 2, 2007.
- Ernst & Young LLP provided consent for the amended report.
- No financial performance data or operational updates are included in this specific filing.